✦ LIBER ✦

13 Long-term oral BCAA supplements in advanced cirrhosis. A double-blind, randomized trial

✍ Scribed by G. Marchesini; G. Bianchi; P. Amodio; M. Merli; C. Panella; C. Loguercio; F. Rossi Fanelli; R. Abbiati

Book ID: 119631695
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 167 KB
Volume: 35
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(03)90014-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized double-blind study of oral

A randomized double-blind study of oral BCAA in patients with cirrhosis

✍ Guilak, Farshid; Butler, David L.; Goldstein, Steven A.; Baaijens, Frank P.T. 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Nutritional supplementation with branche

Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial

✍ Giulio Marchesini; Giampaolo Bianchi; Manuela Merli; Piero Amodio; Carmine Panel 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Oral verapamil for paroxysmal supraveutr

Oral verapamil for paroxysmal supraveutricular tachycardia: A long-term, double-blind, randomized trial

✍ David R. Mauritson; Michael D. Winniford; W.Scott Walker; Robert E. Rude; Joan R 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Effect of a long-term oral l-arginine su

Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial

✍ L. D. Monti; E. Setola; P. C. G. Lucotti; M. M. Marrocco-Trischitta; M. Comola; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 788 KB

Torasemide versus furosemide in cirrhosi

Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study

✍ Fiaccadori, F. ;Pedretti, G. ;Pasetti, G. ;Pizzaferri, P. ;Elia, G. 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 560 KB

The effects of long-term therapy (70 days) with torasemide (20 mg/day), a new loop diuretic, were compared with those of furosemide (50 mg/day) in a randomized double-blind trial. Both drugs were administered in association with spironolactone (200 mg/day) in 28 nonazotemic cirrhotic patients with c

Oral administration of branched chain am

Oral administration of branched chain amino acids (BCAA) in patients with liver cirrhosis. A double-blind, randomized crossover study

📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 108 KB